Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhujun Cao

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Frontiers in Cellular and Infection Microbiology|February 3, 2022
Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B PatientsYan Huang, Qinyi Gan, Rongtao Lai, et al.
Infection and Drug Resistance|November 23, 2018
Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patientsLei Yan, Chuanwu Zhu, Jing Li, et al.
Scientific Reports|November 18, 2016
SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver diseaseYuhan Liu, Fudong Yu, Yan Han, et al.
Frontiers in Physiology|April 5, 2021
A High Percentage of Patients Recovered From COVID-19 but Discharged With Abnormal Liver Function TestsQinyi Gan, Beilei Gong, Manli Sun, et al.
Journal of Viral Hepatitis|April 12, 2019
Serum keratin-18 fragments as cell death biomarker in association with disease progression and prognosis in hepatitis B virus-related cirrhosisZhujun Cao, Liwen Chen, Jing Li, et al.
Cell Reports. Medicine|December 20, 2025
Blood metabolic panels for identifying significant fibrosis and inflammation in patients with MASLDYan Huang, Jiaqi Li, Shuying Song, et al.
Journal of Medical Virology|July 4, 2017
Younger trend of cirrhosis incidence in genotype 3 HCV infected patients in Eastern ChinaJie Lu, Xiaogang Xiang, Zhujun Cao, et al.
Antiviral Research|August 14, 2021
A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in ChinaPeipei Ren, Hu Li, Yan Huang, et al.
Nature Communications|January 20, 2026
Unbiased clustering of acute-on-chronic liver failure patients using machine learning in a real-world ICU cohortMengyi Zhang, Fanpu Ji, Jian Zu, et al.
Oncotarget|December 30, 2017
Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinomaPeng Wang, Ruidong Mo, Rongtao Lai, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Frontiers in Cellular and Infection Microbiology|February 3, 2022
Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B PatientsYan Huang, Qinyi Gan, Rongtao Lai, et al.
Infection and Drug Resistance|November 23, 2018
Entecavir add-on or switch-to pegylated interferon improves HBsAg clearance in HBe antigen negative chronic hepatitis B patientsLei Yan, Chuanwu Zhu, Jing Li, et al.
Scientific Reports|November 18, 2016
SUMO-specific protease 3 is a key regulator for hepatic lipid metabolism in non-alcoholic fatty liver diseaseYuhan Liu, Fudong Yu, Yan Han, et al.
Frontiers in Physiology|April 5, 2021
A High Percentage of Patients Recovered From COVID-19 but Discharged With Abnormal Liver Function TestsQinyi Gan, Beilei Gong, Manli Sun, et al.
Journal of Viral Hepatitis|April 12, 2019
Serum keratin-18 fragments as cell death biomarker in association with disease progression and prognosis in hepatitis B virus-related cirrhosisZhujun Cao, Liwen Chen, Jing Li, et al.
Cell Reports. Medicine|December 20, 2025
Blood metabolic panels for identifying significant fibrosis and inflammation in patients with MASLDYan Huang, Jiaqi Li, Shuying Song, et al.
Journal of Medical Virology|July 4, 2017
Younger trend of cirrhosis incidence in genotype 3 HCV infected patients in Eastern ChinaJie Lu, Xiaogang Xiang, Zhujun Cao, et al.
Antiviral Research|August 14, 2021
A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in ChinaPeipei Ren, Hu Li, Yan Huang, et al.
Nature Communications|January 20, 2026
Unbiased clustering of acute-on-chronic liver failure patients using machine learning in a real-world ICU cohortMengyi Zhang, Fanpu Ji, Jian Zu, et al.
Oncotarget|December 30, 2017
Genetic variations of NTCP are associated with susceptibility to HBV infection and related hepatocellular carcinomaPeng Wang, Ruidong Mo, Rongtao Lai, et al.
Pageof 7